Adagio Medical Holdings shares are trading lower. The company presented six-month results from its FULCRUM-VT Investigational Device Exemption clinical trial.

Benzinga Newsdesk www.benzinga.com Negative 59.5%

Neg 59.5% Neu 0% Pos 0%

Comments

No comments yet. Be the first!